The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Abdominal Radiology"
DOI: 10.1007/s00261-020-02881-0
Abstract: To estimate the role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI (EOB-MRI) in predicting hypervascularization outcome of non-hypervascular hypointense hepatic lesions in high-risk patients for hepatocellular carcinoma (HCC). Under the premise of non-hyperenhance in arterial phase (AP)… read more here.
Keywords: hypointense; non hypervascular; phase; eob mri ... See more keywords
Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan.
Sign Up to like & getrecommendations! Published in 2017 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2017.03.006
Abstract: PURPOSE The objective of the study was to evaluate the cost-effectiveness of gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) in the diagnosis and treatment of hepatocellular carcinoma (HCC) in Japan compared with extracellular contrast media-enhanced MRI… read more here.
Keywords: japan; cost effectiveness; eob mri; mri ... See more keywords
Evaluation of health economic impact of initial diagnostic modality selection for colorectal cancer liver metastases in suspected patients in China, Japan and the USA.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2173436
Abstract: AIMS To compare cost offsets and contributing factors (false-negative rates and confirmatory imaging requirements, potentially leading to longer waiting times for diagnosis) as well as long-term cost effectiveness associated with the diagnostic and treatment pathways… read more here.
Keywords: false negative; cancer liver; eob mri; mri ... See more keywords
Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Acta Radiologica"
DOI: 10.1177/02841851221113265
Abstract: Background Accurate diagnosis of intrahepatic mass-forming cholangiocarcinoma (IMCC) is crucial with regard to the choice of patient management and treatment options. Purpose To evaluate the feasibility and diagnostic performance of the LI-RADS M (LR-M) targetoid… read more here.
Keywords: hcc; rim aphe; eob mri; mri ... See more keywords
A new formula to calculate the resection limit in hepatectomy based on Gd-EOB-DTPA-enhanced magnetic resonance imaging
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0210579
Abstract: Background and aim Dynamic magnetic resonance imaging with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (EOB-MRI) can be used not only to detect liver tumors but also to estimate liver function. The aim of this study was to establish… read more here.
Keywords: hepatectomy; magnetic resonance; eob mri; resection limit ... See more keywords
Automatized Hepatic Tumor Volume Analysis of Neuroendocrine Liver Metastases by Gd-EOB MRI—A Deep-Learning Model to Support Multidisciplinary Cancer Conference Decision-Making
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13112726
Abstract: Simple Summary Quantification of liver metastases on imaging is of utmost importance in therapy response assessment, wherein gadoxetic acid (Gd-EOB)-enhanced magnetic resonance imaging (MRI) shows the highest accuracy. Common criteria for assessing therapy response simplify… read more here.
Keywords: multidisciplinary cancer; response; eob mri; model ... See more keywords
Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14030827
Abstract: Simple Summary Atezolizumab plus bevacizumab therapy has high response rates in patients with unresectable hepatocellular carcinoma (HCC). The hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) has been reported to be useful as an… read more here.
Keywords: hepatobiliary phase; atezolizumab plus; plus bevacizumab; eob mri ... See more keywords
Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15041238
Abstract: Simple Summary Transarterial chemoembolization (TACE) is the recommended treatment for intermediate-stage hepatocellular carcinoma (HCC), and its role as a curative treatment is now greater than previously due to the introduction of targeted molecular and immunotherapies.… read more here.
Keywords: eob mri; intermediate stage; mri; tace ... See more keywords